John A Kusske, MD in Orange, CA - Neurological Surgery

John A Kusske, MD is a Neurological Surgery physician based in Orange, California. John A Kusske is licensed to practice in California (license number 000000A21311) and his current practice location is Uci Medical Center, 101 The City Drive South, Orange, California. He can be reached at his office (for appointments etc.) via phone at (714) 456-8978.

NPI number for John A Kusske is 1275601593 and his current mailing address is Neurosurgical Associate Of Irv, Po Box 54840, Los Angeles, California. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1275601593.

Contact Information

	John A Kusske, MD
	Uci Medical Center, 101 The City Drive South, Orange, CA 92868
	(714) 456-8978
	Not Available

Physician's Profile

Full Name	John A Kusske
Gender	Male
Speciality	Neurological Surgery
Location	Uci Medical Center, Orange, California
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1275601593
Provider Enumeration Date: 12/04/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for John A Kusske such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1275601593	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207T00000X	Neurological Surgery	000000A21311 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. John A Kusske is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
John A Kusske, MD Neurosurgical Associate Of Irv, Po Box 54840, Los Angeles, CA 90054-0840 Ph: (714) 456-6369	John A Kusske, MD Uci Medical Center, 101 The City Drive South, Orange, CA 92868 Ph: (714) 456-8978

News Archive

Nanoparticle-delivered suicide gene therapy effectively reduces ovarian tumor burden in mice

Nanoparticle delivery of diphtheria toxin-encoding DNA that expresses selectively in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect that this therapy could be tested in humans with advanced ovarian cancer within 18 to 24 months, according to a report in Cancer Research. If additional tests are successful, these finding could lead to a new treatment for ovarian cancer, which now causes more than 15,000 deaths each year in the United States. Because it is usually diagnosed at a relatively late stage, ovarian cancer is one of the most deadly forms of the disease.

CEWG recommends WHA adopt international convention on R&D

The chairs of the Consultative Expert Working Group on Research and Development (CEWG), John-Arne Rottingen and Claudia Chamas, in this week's PLoS Medicine, "recommended the May 2012 World Health Assembly adopt an international convention on research and development (R&D) that will bind member states to action and catalyze new knowledge for diseases that primarily affect the global poor but for which patents provide insufficient market incentives," a PLoS press release states.

SPRYCEL receives FDA approval for treating adult patients with Ph+ CML in chronic phase

After receiving a priority review, Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved SPRYCEL (dasatinib) 100 mg once daily for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase.

MonoSol Rx, Midatech collaborate to develop peptides for therapeutic delivery utilizing pharmaceutical films

MonoSol Rx, the developer of PharmFilm® drug delivery technology, today announced the expansion of its agreement with Midatech Group (Oxford, UK) to develop nanoparticle-based proteins and peptides for therapeutic delivery utilizing pharmaceutical films. Under the terms of the expanded agreement, MonoSol Rx has made an equity investment in Midatech and Keith Kendall, Executive Vice President and Chief Financial Officer of MonoSol Rx, will join the Midatech Board of Directors.

Study: Scant proportion of hospitalized patients with opioid use disorder receive treatment

Despite a national opioid-related overdose epidemic that continues to claim tens of thousands of lives annually, a new nationwide study shows that a scant proportion of hospitalized patients with opioid use disorder receive proven life-saving medications both during and after they're discharged.

Neurological Surgery Doctors in Orange, CA

Michelle Paff, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-880-7812
Dr. Maheen Qamar Khan, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-6966
Ichiro Yuki, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S # I, Orange, CA 92868 Phone: 714-456-6966
Dr. Joseph Daniel Lockwood, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 200 S Manchester Ave Ste 210, Orange, CA 92868 Phone: 870-674-4555
Dr. Michael Y Oh, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S Bldg 30, Orange, CA 92868 Phone: 714-456-6966 Fax: 714-456-8212
Michael Kim, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 S Manchester Ave Ste 210, Orange, CA 92868 Phone: 714-456-7495

John A Kusske, MD - Neurological Surgery in Orange, CA